Approval · Notice of Compliance 18311 · 2016

SYNJARDY: Notice of Compliance 18311

Issued July 29, 2016

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 18311
Date: July 29, 2016
Company: Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other

Products in this notice

Brand	DIN	Status today
SYNJARDY	02456575	Marketed
SYNJARDY	02456583	Marketed
SYNJARDY	02456591	Marketed
SYNJARDY	02456605	Marketed
SYNJARDY	02456613	Marketed
SYNJARDY	02456621	Marketed

Medicinal ingredients

METFORMIN HYDROCHLORIDE 500 MG per TAB
EMPAGLIFLOZIN 5 MG per TAB
METFORMIN HYDROCHLORIDE 850 MG per TAB
METFORMIN HYDROCHLORIDE 1,000 MG per TAB
EMPAGLIFLOZIN 12.5 MG per TAB